Holen Sie sich die Stockscreener-App
5.22
3.69%
-0.20
Handel nachbörslich:
5.05
-0.17
-3.26%
Schlusskurs vom Vortag:
$5.42
Offen:
$4.91
24-Stunden-Volumen:
943.33K
Relative Volume:
0.70
Marktkapitalisierung:
$7.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.85M
KGV:
-0.2184
EPS:
-23.9055
Netto-Cashflow:
$-13.83M
1W Leistung:
+9.21%
1M Leistung:
+122.13%
6M Leistung:
-22.55%
1J Leistung:
-60.45%
1-Tages-Spanne:
$4.68
$5.61
1-Wochen-Bereich:
$4.65
$5.61
52-Wochen-Spanne:
$1.90
$13.80
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Firmenname
Cns Pharmaceuticals Inc
Sektor
Branche
Telefon
1-800-946-9185
Adresse
2100 WEST LOOP SOUTH, HOUSTON
Compare CNSP vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
5.22 | 7.92M | 0 | -15.85M | -13.83M | -23.91 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Eingeleitet | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten
CNS Pharmaceuticals (NASDAQ: CNSP) registers 9.79M resale shares from May private placement - Stock Titan
CNSP SEC FilingsCNS Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buying: Faith Charles Acquires Shares of CNS Pharmaceuti - GuruFocus
CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock By Investing.com - Investing.com Canada
CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock - Investing.com
CNSP | CNS Pharmaceuticals, Inc. Common Insider Trading - Quiver Quantitative
[Form 4] CNS Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress - Weatherford Democrat
CNS Pharmaceuticals Registers 9.79 Million Shares for Selling Holders - Moomoo
CNS Pharmaceuticals (CNSP) registers 9.79M shares including prefunded warrants - Stock Titan
cns pharmaceuticals inc Earnings dates - RTTNews
NRXP: Advanced CNS drug pipeline, reduced net loss, and expanded clinical footprint in Q1 2026 - TradingView
Stonepine (CNSP) reports 159,790 shares; 9.9% position disclosed - Stock Titan
Maxim Group Maintains CNS Pharmaceuticals(CNSP.US) With Buy Rating, Maintains Target Price $10 - Moomoo
CNSP Poised for Growth Through Strategic Initiatives - GuruFocus
CNS Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CNSP's Financial Outlook After Recent Fundraising - GuruFocus
CNS Pharmaceuticals, Inc. Q1 2026 Financials and Corporate Strategy Update – 10-Q Report Highlights - Minichart
CNS Pharmaceuticals : CNSP - 24/7 Wall St.
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress - ACCESS Newswire
Biotech CNS Pharmaceuticals secures $22.5M to buy neurology, oncology drugs - Stock Titan
CNS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CNS Pharmaceuticals (CNSP) widens Q1 loss but secures $22.5M private placement - Stock Titan
ACADIA Pharmaceuticals stock (US0042251084): Biotech decline amid CNS focus - AD HOC NEWS
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6 - 24/7 Wall St.
TradingKey - TradingKey
CNS Pharmaceuticals Inc expected to post a loss of $5.37 a shareEarnings Preview - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why did CNSP stock surge 330% today? - MSN
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing - ACCESS Newswire
ACADIA Pharmaceuticals stock (US0042251084): Focus on CNS drug pipeline and commercial execution - AD HOC NEWS
Is CNS Pharma (CNSP) stock hiding in plain sight? (Trend Strengthens) 2026-05-08Trending Volume Leaders - newser.com
CNS Pharmaceuticals Company Profile & Introduction - Moomoo
What's Going On With CNS Pharmaceuticals Stock On Wednesday? - Sahm
Nano-Cap CNS Pharmaceuticals Stock Explodes As Capital Raise Fuels Pivot - Sahm
Nano-cap CNS Pharmaceuticals stock explodes as capital raise fuels pivot - MSN
CNS Pharma sees 250% spike from oversubscribed private placement - Mugglehead Investment Magazine
CNS Pharmaceuticals (CNSP) Stock Skyrockets 215% on $22.5M Funding Round - MEXC Exchange
Why CNS Pharmaceuticals (CNSP) Stock Is Up 215% Today - MEXC
Why Did CNSP Stock Surge 330% Today? - Stocktwits
CNSP Secures $22.5 Million in Private Placement Financing - GuruFocus
CNS Pharmaceuticals (CNSP) Stock Skyrockets 215% on $22.5M Fundraise - MEXC
CNS Pharmaceuticals Raises $22.5 Million in Private Placement to Fuel Asset Acquisition - MEXC
CNS Pharmaceuticals (NASDAQ: CNSP) Secures $22.5M Private Placement Financing - The Globe and Mail
Gold Falls Over 2%; US Factory Orders Rise In March - Benzinga
CNS Pharmaceuticals Announces Private Placement Agreement and Pre-Funded Warrants Offering – Details and Legal Terms - Minichart
Why is CNS Pharmaceuticals stock up 250% today? By Investing.com - Investing.com Nigeria
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):